JUNE STOCK TALK II
Closed at 2.21. What a complete farking dumb gdmf-ing sucker I was to chase at that price (2500 x 2.92). But, for reasons I cannot explain, had I done nothing with it but watch, then it would've probably blown off today and closed well north of 3. Way this stuff goes.
No positions anywhere...........got to recuperate and lick wounds for a few days. Almost everything I made shorting SP 500 on Friday was vaporized today with this gd QTWW.
QTWW just got torn to pieces today on HUGE volume. Its chart got completely annihilated by the manipulators today. They wanted it down, and they took it down. Anyone in their way (like my sorry ass)..................![]()
Closed at 2.21. What a complete farking dumb gdmf-ing sucker I was to chase at that price (2500 x 2.92). But, for reasons I cannot explain, had I done nothing with it but watch, then it would've probably blown off today and closed well north of 3. Way this stuff goes.
No positions anywhere...........got to recuperate and lick wounds for a few days. Almost everything I made shorting SP 500 on Friday was vaporized today with this gd QTWW.
QTWW just got torn to pieces today on HUGE volume. Its chart got completely annihilated by the manipulators today. They wanted it down, and they took it down. Anyone in their way (like my sorry ass)..................![]()
lol
They have an investors update on Thu I think where they are going to announce results of a study and some other things, the stock is moving ahead of that..
lol
They have an investors update on Thu I think where they are going to announce results of a study and some other things, the stock is moving ahead of that..
Looking at the prospects, if they were to ever get their crap together and start marketing the products and get them used, this market cap is a 5 bagger or more.
Looking at the prospects, if they were to ever get their crap together and start marketing the products and get them used, this market cap is a 5 bagger or more.
What I hope is that some of the weak longs are out, ones that were waiting to sell.
Get new money in there, let the people who want out to get out.
I am in this for a longer term, for bigger profits than a one day pop.
What I hope is that some of the weak longs are out, ones that were waiting to sell.
Get new money in there, let the people who want out to get out.
I am in this for a longer term, for bigger profits than a one day pop.
I dont blame you fellas for taking profits if you do, that wouldnt offend me in the slightest. I have a large number of shares but I am not looking for a one day pop and I am willing to ride the swings because if they can get their marketing going and product in the hands of surgeons, this market cap is nothing to what could happen.
I also bot more DRYS shares and options today.
I dont blame you fellas for taking profits if you do, that wouldnt offend me in the slightest. I have a large number of shares but I am not looking for a one day pop and I am willing to ride the swings because if they can get their marketing going and product in the hands of surgeons, this market cap is nothing to what could happen.
I also bot more DRYS shares and options today.
I dont blame you guys..you have a profit on the table, almost 30% and who could sneeze at that?
If you feel the need then do what you feel is best.
I could be completely wrong and this could reverse tomorrow. My shares are long term and I am willing to ride it out because I see the economic value in their product and possible market dominance.
I dont blame you guys..you have a profit on the table, almost 30% and who could sneeze at that?
If you feel the need then do what you feel is best.
I could be completely wrong and this could reverse tomorrow. My shares are long term and I am willing to ride it out because I see the economic value in their product and possible market dominance.
The Company announced that data from the 220-patient prospective, randomized pivotal clinical trial of its PAS-Port(R) Proximal Anastomosis System will be presented at the 2008 Annual Scientific Meeting of the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) in Boston. The presentation, entitled "The Cardica PAS-Port Proximal Anastomotic Connector Device: First Report of the Results of the FDA Trial," will be given during the Late Breaking News session on Thursday, June 12, at 1:15 p.m. Eastern Time by principal study investigator John D. Puskas, M.D., chief of cardiac surgery at Emory Crawford Long Hospital in Atlanta. As previously announced, the trial, which compared graft vessel connections made using the PAS-Port system to conventional hand-sewn sutures during CABG procedures, achieved all of its primary and secondary endpoints. Based on the positive trial data, Cardica submitted a 510(k) premarket notification in April to the U.S. Food and Drug Administration for the PAS-Port system.
Panelists for the investor event will include: -- Husam H. Balkhy, M.D., chairman of cardiothoracic surgery at The Wisconsin Heart Hospital and clinical assistant professor of surgery at the Medical College of Wisconsin. He is a well-known advocate of minimally-invasive cardiac surgery and has the largest experience in the United States with distal anastomotic devices in coronary artery bypass. -- Robert S. Poston, M.D., chief of cardiac surgery at Boston Medical Center. Previously, he was an associate professor of surgery at the University of Maryland where he focused his activities in the field of off-pump and minimally-invasive/robotic CABG. His research into minimally-invasive CABG and the hybrid procedure was recognized in 2005 by the Daily Record magazine as an "Innovation of the Year." -- Sudhir Srivastava, M.D., director of robotic and minimally-invasive cardiac surgery at the University of Chicago Medical Center. He pioneered both the da Vinci revascularization and port-only coronary artery bypass surgical methods and has performed more of these procedures than any other surgeon in the world.Webcast Details
The event will be webcast live on Thursday, June 12, at 5:15 p.m. Eastern Time. To access the live and subsequently archived webcast of the discussion, go to the Investor Relations section of Cardica's website at https://www.cardica.com. Please connect to the website at least 15 minutes prior to the webcast to allow for any necessary software downloads.
My guess is that people started digging, and good news got leaked. and short sellers got squeezed, to boot
The Company announced that data from the 220-patient prospective, randomized pivotal clinical trial of its PAS-Port(R) Proximal Anastomosis System will be presented at the 2008 Annual Scientific Meeting of the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) in Boston. The presentation, entitled "The Cardica PAS-Port Proximal Anastomotic Connector Device: First Report of the Results of the FDA Trial," will be given during the Late Breaking News session on Thursday, June 12, at 1:15 p.m. Eastern Time by principal study investigator John D. Puskas, M.D., chief of cardiac surgery at Emory Crawford Long Hospital in Atlanta. As previously announced, the trial, which compared graft vessel connections made using the PAS-Port system to conventional hand-sewn sutures during CABG procedures, achieved all of its primary and secondary endpoints. Based on the positive trial data, Cardica submitted a 510(k) premarket notification in April to the U.S. Food and Drug Administration for the PAS-Port system.
Panelists for the investor event will include: -- Husam H. Balkhy, M.D., chairman of cardiothoracic surgery at The Wisconsin Heart Hospital and clinical assistant professor of surgery at the Medical College of Wisconsin. He is a well-known advocate of minimally-invasive cardiac surgery and has the largest experience in the United States with distal anastomotic devices in coronary artery bypass. -- Robert S. Poston, M.D., chief of cardiac surgery at Boston Medical Center. Previously, he was an associate professor of surgery at the University of Maryland where he focused his activities in the field of off-pump and minimally-invasive/robotic CABG. His research into minimally-invasive CABG and the hybrid procedure was recognized in 2005 by the Daily Record magazine as an "Innovation of the Year." -- Sudhir Srivastava, M.D., director of robotic and minimally-invasive cardiac surgery at the University of Chicago Medical Center. He pioneered both the da Vinci revascularization and port-only coronary artery bypass surgical methods and has performed more of these procedures than any other surgeon in the world.Webcast Details
The event will be webcast live on Thursday, June 12, at 5:15 p.m. Eastern Time. To access the live and subsequently archived webcast of the discussion, go to the Investor Relations section of Cardica's website at https://www.cardica.com. Please connect to the website at least 15 minutes prior to the webcast to allow for any necessary software downloads.
My guess is that people started digging, and good news got leaked. and short sellers got squeezed, to boot
Funny we saw that news and nothing happened initially..so I didnt think much of it. Obviously something was leaked and the buying was nibbles early, then at noon EST someone put some money to work and the bigger buying started-
LINK
Then look at 1:15 and the 35k on the offer got snuffed out and removed. After that I think it hit some radars and some players came and got involved.
I think the trial went well, as all of us that know the company would expect and that trial success will open the door and since it is being presented at a big conference like that, it will be known in the industry and is great for the company.
I dont think the stock is going off the charts from here, and it SHOULD retrace..but if it doesnt, I cannot be sure of that either.
Taking a 1/4 position would be ok, but I really think the stock comes in after the conference.
HAT...what you are reading is that a stock you own is going to require more margin if you are using margin. Here is an example-
Stock RIMM (all hypothetical) currently at broker X has a 50% margin requirement..that means if you are buying it using margin, you must hold in equity 50% of the position..so like this-
RIMM is 100 bucks (hypothetical) you own 100 shares, that is 10k in money, but if you were using margin it would mean that the broker only requires you to keep 5k to hold the 100 shares, the rest is on "margin" or borrowed money from the firm, and in return you pay a margin interest rate to the firm.
Now...RIMM has gone crazy it is a riskier stock (hypothetical) and the brokerage feels the margin maintenance requirement needs to be 75%, now instead of needing to have 5k in CASH in the account, you must have 7500 bucks. It means the broker needs you to hold more cash to use margin with the stock.
Does that help?
Funny we saw that news and nothing happened initially..so I didnt think much of it. Obviously something was leaked and the buying was nibbles early, then at noon EST someone put some money to work and the bigger buying started-
LINK
Then look at 1:15 and the 35k on the offer got snuffed out and removed. After that I think it hit some radars and some players came and got involved.
I think the trial went well, as all of us that know the company would expect and that trial success will open the door and since it is being presented at a big conference like that, it will be known in the industry and is great for the company.
I dont think the stock is going off the charts from here, and it SHOULD retrace..but if it doesnt, I cannot be sure of that either.
Taking a 1/4 position would be ok, but I really think the stock comes in after the conference.
HAT...what you are reading is that a stock you own is going to require more margin if you are using margin. Here is an example-
Stock RIMM (all hypothetical) currently at broker X has a 50% margin requirement..that means if you are buying it using margin, you must hold in equity 50% of the position..so like this-
RIMM is 100 bucks (hypothetical) you own 100 shares, that is 10k in money, but if you were using margin it would mean that the broker only requires you to keep 5k to hold the 100 shares, the rest is on "margin" or borrowed money from the firm, and in return you pay a margin interest rate to the firm.
Now...RIMM has gone crazy it is a riskier stock (hypothetical) and the brokerage feels the margin maintenance requirement needs to be 75%, now instead of needing to have 5k in CASH in the account, you must have 7500 bucks. It means the broker needs you to hold more cash to use margin with the stock.
Does that help?
Hot Forum Topics
- Tuesday 11/10/2026 350
- BEAT Your book 127,557
- 🏈🏈🏈 Fubah2's risky CFB bets 300,732
- I'm embarrassed for Trump supporters 63,592
- $$ALL IN ( 2x5uNIT=1-O,5UnitUNDER=4-2,5Unit over=1-O,5Unit ATS=2-O,2Unit=4-o_ =+ 43 Units 5,695
- Florida Man Tuesday 4,288
- *EdgeHunter Ohio VS Miami Ohio - NEW WEEK, NEW MONEY!* 2,876
- Bags Tuesday LARGE **Michigan State vs Duke** 2,357
- Trump's legacy? 37,169
- Week 11 Money 2,817
Warning - External Link
Report User
This post is spam
Delete Post
Remove Thread
Scan Results
Login/Register
Accounts are free and easy to create.
Search
